Valganciclovir modulates the TNF axis molecules expression and CD4+ T cell subsets in disseminated Kaposi Sarcoma patients

In conclusion, VGC, as an add-on therapy in DKS/HIV patients, gradually modulates the activation of CD4+ T cell subsets and the TNF/TNFRs axis, suggesting a better regulation of the inflammatory status.PMID:37904542 | DOI:10.1093/cei/uxad115
Source: Clinical and Developmental Immunology - Category: Allergy & Immunology Authors: Source Type: research